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1. Introduction 
Biothiols play many crucial roles in intracellular antioxidant 
defense systems.[1] Glutathione (GSH), for example, the most 
prevalent intracellular non-protein thiol ranges in concentration 
from 1 to 15 mM depending on the cell type.[2-5] It is a natural 
tripeptide (γ-L-glutamyl-cysteinyl-glycine) that exists in the thiol 
reduced form (GSH) and disulphide-oxidised (GSSG) form.[6] 
GSH serves many cellular functions, including the protection of 
cellular components against oxidative stress, redox homeostasis, 
and intracellular signal transduction.[1,7-9] However, an imbalance 
of GSH is observed for a wide range of pathologies, including 
cancer, Parkinson’s disease, HIV and aging.[10-12] Therefore, 
significant effort has been devoted towards the development of 
efficient fluorescent probes for the detection of GSH.[13-15] While, 
many of these fluorescent probes have focused on the detection of 
a single biomarker (GSH), many processes associated with GSH 
often involve more than one biochemical species. For example, 
while hypoxia is reported to decrease cellular GSH stores,[16] 
maternal hypoxia has been reported to facilitate fetal liver GSH 
production.[21] Hypoxia is caused by an insufficient supply of 
oxygen[9] and can result in increased reductive stress; a 
consequence of the upregulation of various reductive enzymes 
such as nitroreductase (NTR).[17] Indeed, upregulation of NTR has 
been associated with various health problems, including 
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inflammatory disease, solid tumors, and stroke.[18-20] Hence, the 
development of methods that help explore the relationships 
between GSH and NTR are of great importance in terms of 
pathological analysis and early diagnostics. 
As a useful analytical tool, fluorescence spectroscopy is of 
broad interest in bioanalysis.[22] Fluorescence-based small-
molecule probes are able to selectively sense and image analytes 
through the utilization various chemical reactions, furthermore, 
fluorescent probes are often less invasive and more convenient 
than many other methods for the detection of biologically-relevant 
cellular targets.[23,24] Recently, a number of fluorescence-based 
probes for dual or multi-analyte detection have been developed.[25-
27] These types of fluorescent probes have been used for the 
construction of molecular logic gates and/or for medical 
diagnostics.[28] AND logic-based fluorescent probes require both 
analytes to be simultaneously present or work in tandem in order 
to elicit a fluorescence response, and provide different information 
to that available from serial measurements of two analytes within 
the same biological system. 
In our group, we have recently focused on developing dual 
analyte activated probes.[29-33] With this design principle in mind, 
we identified a suitable fluorophore based on coumarin __3-amino-
7-hydroxy-2H-chromen-2-one (AHC). We anticipated that its free 
phenol and amine functionalities could provide an excellent 
opportunity for differential derivatization (Scheme 1). 
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With this research we set out to develop a coumarin-based novel fluorescent probe NTR-AHC for 
the detection of biological thiols and nitroreductase (NTR). Probe NTR-AHC was constructed by 
attaching the NTR trigger moiety (p-nitrobenzyl) and biothiol acceptor (maleic acid monoamide), 
to the core fluorophore AHC. In the presence of both glutathione (GSH) and NTR, probe NTR-
AHC produced a >8-fold increase in fluorescence intensity at 463 nm. 






Furthermore, coumarins are an important structural element of 
various compounds with biological activities including 
compounds with anticancer,[34] antiproliferative,[35] antioxidant,[36] 
and antifungal activities.[37] Previous literature reports indicate that 
the protection of AHC with a maleic acid monoamide group 
results in fluorescence quenching of the coumarin’s fluorescence 
due to a photoinduced electron transfer (PeT) process, the 
fluorescence is rapidly restored in the presence of biological thiols 
due to their fast addition to this functional group.[38] Therefore, we 
envisioned that functionalization of the free phenol of this probe 
using a p-nitrobenzyl should further quench the fluorescence, 
whilst serving as a selectivity reporter unit toward NTR over other 
various analytes.[39,40] Consequently, with this research we 
anticipated that the attachment of a NTR and GSH differentiating 
motif to AHC could produce a selective fluorescent probe NTR-









Scheme 2. Reaction mechanism of NTR-AHC with GSH and nitroreducase (NTR) and NADPH. 
 
2. Results and discussion 
We evaluated the ability of NTR-AHC to detect GSH ‘AND’ 
NTR in PBS buffer solution (10 mM, pH 7.40, containing 1% 
DMSO). The maximum absorption of NTR-AHC at 344 nm 
shifted to 340 nm upon addition of GSH with a significant increase 
at 340 nm following the addition of NTR (Fig. S1). As shown in 
Fig. 1, probe NTR-AHC was initially non-fluorescent, and 
exhibited a small fluorescence increase upon  
 
addition of GSH (5 µM) (Fig. S2), however, the successive 
addition of NTR (10 µg mL–1) and NADPH (400 µM) led to a 
significant and time dependent increase in fluorescence intensity 
(>8-fold). These results illustrated the requirement for both GSH 
‘AND’ NTR to obtain a significant turn ‘on’ fluorescence 
response. We then evaluated the kinetic behavior of NTR-AHC 
with both GSH and NTR (Fig. 2 and 3) and determined that NTR-
AHC exhibits a dose dependent fluorescence increase in response 
of both GSH and NTR. 
 
Fig. 1 Fluorescence spectra of NTR-AHC (10.0 µM) with initial 
addition of GSH (5 µM) incubated for 20 min, followed by the 
addition of NADPH (400 µM) and NTR (10 µg mL–1) monitored for 
a further 90 minutes in PBS buffer solution (pH=7.4, 10 mM, 
containing 1% DMSO). λex = 365 nm. Ex slit: 5 nm and em slit: 5 nm. 
Dashed line represents NTR-AHC and GSH addition only. Blue line 
represents highest intensity after addition of NTR. 
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Fig. 2 Fluorescence intensity changes at 463 nm of NTR-AHC (10.0 
µM) with initial addition of GSH (5.0 µM) incubated for 20 min, 
followed by the addition of NADPH (400 µM) and NTR (2.0 – 15.0 
µg mL–1) in PBS buffer (pH=7.4, 10 mM, containing 1% DMSO). λex 
= 365 nm. Ex slit: 5 nm and em slit: 5 nm. 
 
 
Fig. 3 Fluorescence spectra of NTR-AHC (10.0 µM) with initial addition of GSH (5.0 µM) incubated for 20 min (dashed line), followed by the 
addition of NADPH (400 µM) and NTR ((a) 2 µg mL–1, (b) 7 µg mL–1, (c) 10 µg mL–1, (d) 15 µg mL–1) monitored for a further 90 minutes in 
PBS buffer (pH=7.4, 10 mM, containing 1% DMSO). λex = 365 nm. Ex slit: 5 nm and em slit: 5 nm. 
 
To ensure both analytes were required, the same fluorescence 
experiments were then carried out in reverse order, NTR and 
NADPH was kept constant (10 µg mL–1 and 400 µM, respectively) 
resulting in a large fluorescence increase (Fig. 4), attributed to the 
background fluorescence of NADPH.[41] Subsequent addition of 
GSH (200 µM) led to a 1.2-fold increase in fluorescence intensity.  
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Fig. 4 Fluorescence spectra of NTR-AHC (10.0 µM) with initial 
addition of NADPH (400 µM) and NTR (10 µg mL–1) incubated for 
90 min, followed by the addition of GSH (200 µM) monitored for a 
further 40 minutes in PBS buffer (pH=7.4, 10 mM, containing 1% 
DMSO). λex = 365 nm. Ex slit: 5 nm and em slit: 5 nm. Dashed line 
represents NTR-AHC and NTR addition. Blue line represents highest 
intensity after addition of GSH. 
3. Conclusions 
We have developed a novel coumarin-based fluorescent probe 
NTR-AHC for the detection of biological thiols and NTR, 
respectively, however, an optimum response was only obtained if 
GSH was added first followed by NADPH and NTR, while, the 
reverse sequence does not show significant fluorescence changes, 
which we attribute to a large initial increase to the background 
fluorescence by NADPH and potential oxidation of the GSH by 
NADP+ [42,43] generated during the NTR/NADH catalyzed 
reduction of NTR-AHC.[44] In summary, AHC is a useful core unit 
for the development of coumarin-based dual-analyte ‘AND’ logic 
fluorescent probes. 
4. Experimental section 
4.1. Chemicals and reagents 
All starting materials and reagents were purchased from Sigma 
Aldrich, Alfa Aesar, Fluorochem, or Acros Organics, and used as 
received without any further purification. Unless otherwise stated, 
all solvents used were reagent grade and were used without 
distillation. All water was deionized which is generated by a 
reverse osmosis (Ultra-Purified Type I, 18.2 Megohm water). 
Thin-layer chromatography was performed using commercially 
available Fluorochem aluminum-backed plates coated with a layer 
of silica gel (60 Å) with fluorescent indicator UV254. These plates 
were visualized using ultraviolet light with a wavelength of either 
254 or 365 nm. Silica gel column chromatography was carried out 
using Sigma Aldrich 60 Å silica gel (200-400 mesh). All NMR 
spectra were obtained using an Agilent ProPulse 500 and analyzed 
using MestreNova. LC-MS analyses were performed using an 
Agilent QTOF 6545 mass spectrometer, IR spectra were obtained 
using a Thermo Fisher Nicolet iS5 FTIR spectrometer and 
analyzed using OMNIC (version 9.7.7). 
 
4.2.  Synthesis of NTR-AHC 
Compounds 1-4 were synthesized using adapted literature 
procedures (Scheme S1).[45,38,29] Compound 4 (300 mg, 1.04 mmol) 
was dissolved in dry DMF (5 mL) and K2CO3 (215 mg, 3.15 mmol) 
was added with stirring. 4-nitrobenzyl bromide (249 mg, 1.157 
mmol) was then added and the reaction was stirred for four hours 
at room temperature under a N2 atmosphere. The reaction mixture 
was diluted with EtOAc (90 mL) and washed with brine (90 mL × 
3), dried over anhydrous Na2SO4 and concentrated in vacuo. The 
crude product obtained was purified by flash chromatography 
(SiO2, 30% EtOAc in petroleum ether) to afford the desired yellow 
solid NTR-AHC (198 mg, 48%) (Scheme 1). M.p. 127 – 129 oC; 
1H NMR (500 MHz, DMSO-d6) δH 10.12 (s, 1H), 8.63 (s, 1H), 8.27 
(d, J = 8.5 Hz, 2H), 7.74 (d, J = 8.4 Hz, 2H), 7.71(d, J = 8.6 Hz, 
1H), 7.11 (s, 1H), 7.07 (d, J = 8.6 Hz, 1H), 6.73 (d, J = 11.8 Hz, 
1H), 6.51 (d, J = 11.7 Hz, 1H), 5.39 (s, 2H), 3.69 (s, 3H). 13C NMR 
(126 MHz, DMSO-d6) δC 167.1, 163.3, 159.5, 157.5, 151.4, 147.1, 
144.2, 131.1, 129.4, 129.2, 128.4, 125.7, 123.6, 121.7, 113.4, 
113.1, 101.6, 68.6, 51.6. FTIR (ATR, cm-1): 3309 (N-H), 2955 (C-
H, alkyl), 1721 (C=O), 1708 (C=O), 1605 (C=C), 1247 (C-N). 
HRMS (ESI+): calculated [M+Na]+ 447.0799 m/z, found 447.0798 
m/z, M represents C21H16N2O8 (chemical formula of NTR-AHC). 
 
4.3. Equipment and spectral measurements 
All Fluorescence emission spectra were recorded on a Jasco FP-
6300 spectrofluorometer. Excitation and emission slit widths were 
both set at 5.0 nm. The UV–visible absorption spectra were 
measured at room temperature on a Jasco V-630-Bio 
Spectrometer. Nuclear Magnetic Resonance (NMR) spectroscopy 
experiments were performed in deuterated solvent at 298 K on an 
Agilent ProPulse 500 MHz spectrometer. 
 
4.4.  Preparation of samples for analysis 
NTR-AHC was dissolved in DMSO and a stock solution (0.1 
mM) prepared in PBS buffer (pH =7.4). NTR stock solutions were 
prepared by dissolving 1 mg of enzyme in 1 mL of PBS buffer 
solution and individual ampules were stored in the freezer before 
being thawed and used in each experiment. Stock solutions of 
NADPH (2 mM) and GSH (0.1 mM) were prepared in PBS buffer 
(pH =7.4).  
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